Prospect, KY, United States of America

Elsa Merit Reyes-Reyes


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016-2017

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Elsa Merit Reyes-Reyes

Introduction

Elsa Merit Reyes-Reyes is a notable inventor based in Prospect, Kentucky. She has made significant contributions to the field of pharmaceutical compositions and methods for treating diseases, particularly cancer. With a total of two patents to her name, her work focuses on innovative approaches to modulating DNMT1 inhibitor activity.

Latest Patents

Her latest patents include "Compositions and methods for modulating DNMT1 inhibitor activity." This invention involves methods for attenuating DNMT1 inhibitor activity in animals through the administration of antioxidants. Additionally, it encompasses methods that include administering a composition comprising a DNMT1 inhibitor and an antioxidant, particularly in animals undergoing cancer treatment. Another patent, "Compounds, compositions, pharmaceutical compositions, and methods of use," features compositions that include a compound of Formula (I), along with its salts, isomers, and derivatives. This invention also outlines methods for treating diseases, including cancer, and administering the specified compounds.

Career Highlights

Elsa is affiliated with the University of Louisville Research Foundation, Inc., where she continues to advance her research and innovations. Her work has the potential to impact cancer treatment significantly, showcasing her dedication to improving health outcomes.

Collaborations

Elsa has collaborated with esteemed colleagues, including Paula J Bates and Gerald B Hammond, further enhancing the scope and impact of her research.

Conclusion

Elsa Merit Reyes-Reyes exemplifies the spirit of innovation in the field of pharmaceutical research. Her contributions through her patents reflect her commitment to advancing medical science and improving treatment options for cancer patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…